ABSTRACT
Effective management of spasticity needs to continue during this time, remembering that this period may be many months or even years for some people. Included in palliative care will be the assessment and management of spasticity, in association with all of the other symptoms and issues that the person may be facing. Well-planned end-of-life care is not only beneficial for the person and their families, but through preventing unnecessary admissions to acute healthcare settings, it may also reduce financial costs to society. Pharmacological management of spasticity with medication at the end of life depends on what the person has required up to that point. Many people develop terminal agitation; however, it is important to remember that this is a diagnosis of exclusion and must only be concluded once other causes of agitation have been ruled out. The management of spasticity at the end of life may be complex but must never be viewed in isolation.
